Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Objective: Treatment options for moderate to severe skin psoriasis have considerably progressed over the past
decades with the widespread use of targeted biologicals including Tumor Necrosis Factor antagonists (TNFa).
Objective and reliable analytical assessments of the disease course and the treatment efficacy are eagerly awaited.
Methods: To disclose initial therapeutic effects of the adalimumab TNFa in a group of 13 psoriatic patients. The
analytical observations relied on two in vivo real-time non-invasive methods, namely Reflectance Confocal
Microscopy (RCM) and skin capacitance mapping (SCM). The L* colorimetric assessment of pictures was used for
analytical assessments.
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi